# Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions

> **NCT06313801** · PHASE2 · RECRUITING · sponsor: **Nizhny Novgorod Regional Clinical Oncology Center** · enrollment: 106 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Docetaxel
- **DRUG:** Oxaliplatin
- **DRUG:** Calcium folinate
- **DRUG:** Fluorouracil
- **PROCEDURE:** Diagnostic laparoscopy
- **COMBINATION_PRODUCT:** dPIPAC ( The description of the standard diagnostic laparoscopy procedure and the session of PIPAC (dPIPAC)).

## Key facts

- **NCT ID:** NCT06313801
- **Lead sponsor:** Nizhny Novgorod Regional Clinical Oncology Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-19
- **Primary completion:** 2026-07-01
- **Final completion:** 2027-09-01
- **Target enrollment:** 106 (ESTIMATED)
- **Last updated:** 2025-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06313801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06313801, "Comparing the Safety and Efficacy of First-line Polychemotherapy and Polychemotherapy in Combination With PIPAC Sessions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06313801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*